Price
Target price
€0.028
€0.028
-3.450%
-0.001
-3.450%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Investigator
sharewise wants to provide you with the best news and tools for Investigator, so we directly link to the best financial data sources.
Financials
News
Palvella Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Palvella Therapeutics, Inc.? Here are five stocks we like better.
- Palvella remains on track to submit its NDA for QTORIN rapamycin in microcystic lymphatic
Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout
Key Points
- Interested in Turn Therapeutics Inc.? Here are five stocks we like better.
- Turn Therapeutics refined the stage two design of its GX-03 phase II eczema trial after an interim